|
1
|
Kopelman PG: Obesity as a medical problem.
Nature. 404:635–643. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Catalano PM: Trying to understand
gestational diabetes. Diabet Med. 31:273–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cundy T, Ackermann E and Ryan EA:
Gestational diabetes new criteria may tripli the prevalence but
effect on outcomes is unclear. BMJ. 348:g15672014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steegers EA, von Dadelszen P, Duvekot JJ
and Pijnenborg R: Preeclampsia. Lancet. 376:631–644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Committee Opinion No. 638: First-trimester
risk assessment for early-onset preeclampsia. Obstet Gynecol.
126:e25–e27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lo JO, Mission JF and Caughey AB:
Hypertensive disease of pregnancy and maternal mortality. Curr Opin
Obstet Gynecol. 25:124–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CW, Jaffe IZ and Karumanchi SA:
Preeclampsia and cardiovascular disease. Cardiovasc Res.
101:579–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Engeland A, Bjørge T, Daltveit AK,
Skurtveit S, Vangen S, Vollset SE and Furu K: Risk of diabetes
after gestational diabetes and preeclampsia. A registry-based study
of 230,000 women in Norway. Eur J Epidemiol. 26:157–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiwani A, Marseille E, Lohse N, Damm P,
Hod M and Kahn JG: Gestational diabetes mellitus: Results from a
survey of country prevalence and practices. J Matern Fetal Neonatal
Med. 25:600–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pantham P, Aye IL and Powell TL:
Inflammation in maternal obesity and gestational mellitus.
Placenta. 36:709–715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao W, Wang X, Chen T, Zhu H, Xu W, Zhao
S, Cheng X and Xia L: The expression of Notch/Notch Ligand, IL-35,
IL-17, and Th17/Treg in preeclampsia. Dis Markers. 2015:3161822015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gaffen SL, Jain R, Garg AV and Cua DJ: The
IL-23-IL-17 immune axis: From mechanisms to therapeutic testing.
Nat Rev Immunol. 14:585–600. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saito S: Th17 cells and regulatory T
cells: New light on pathophysiology of preeclampsia. Immunol Cell
Biol. 88:615–617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laresgoiti-Servitje E: A leading role for
the immune system in the pathophysiology of preeclampsia. J Leukoc
Biol. 94:247–257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gratz IK, Rosenblum MD, Maurano MM, Paw
JS, Truong HA, Marshak-Rothstein A and Abbas AK: Self antigen
controls the balance between effector and regulatory T cells in
peripheral tissues. J Immunol. 192:1351–1355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanidaizar D and Koulmanda M: Inflammation
and the balance of Treg and Th17 cells in transplant rejection and
tolerance. Curr Opin Organ Transplant. 15:411–415. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Erlebacher A: Mechanisms of T cell
tolerance towards the allogeneic fetus. Nat Rey Immunol. 13:23–33.
2013. View
Article : Google Scholar
|
|
18
|
Collison LW, Workman CJ, Kuo TT, Boyd K,
Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS and Vignali DA:
The inhibitory cytokine IL-35 contributes to regulatory T-cell
function. Nature. 450:566–569. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Collison LW, Chaturvedi V, Henderson AL,
Glacomin PR, Guy C, Bankorti J, Finkelstein D, Forbes K, Workman
CJ, Brown SA, et al: IL-35-mediated induction of a potent
regulatory T cell population. Nat Immunol. 11:1093–1101. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kashanian M, Aghbali F and Mahahi N:
Evaluation of the diagnostic value of the first trimester maternal
serum high-sensitivity C-reactive protein level for prediction of
pre-eclampsia. J Obstet Gynaecol Res. 39:1549–1554. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeb A: Triglyceride composition, oxidation
and oxidation compounds in camellia oil using liquid
chromatography-mass spectrometry. Chem Phys Lipids. 165:608–614.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gohil JT, Patel PK and Gupta P: Estimation
of lipid profile in subjects of pre-eclampsia. J Obstet Gynaecol
India. 61:399–403. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gaillard R, Durmuş B, Hofman A, Mackenbach
JP, Steegers EA and Jaddoe VW: Risk factors and outcomes of
maternal obesity and excessive weight gain during pregnancy.
Obesity (Silver Spring). 21:1046–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guariguata L, Whiting DR, Hambleton I,
Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes Res Clin
Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Flegal K, Graubard B, Williamson D and
Gail M: Excess deaths associated with underweight, overweight, and
obesity. JAMA. 293:1861–1867. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kotsis V, Stabouli S, Papakatsika S, Rizos
Z and Parati G: Mechanisms of obesity-induced hypertension.
Hypertens Res. 33:386–393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
American Diabetes Association: Standards
of medical care in diabetes-2009. Diabetes Care. 32 Suppl
1:S13–S61. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Far Arjmandi M, Ziaei S and Kazemnejad A:
The impact of maternal age, pre-pregnancy body mass index, weight
gain and parity on glucose challenge test (GCT). Int J Fertil
Steril. 5:207–2010. 2012.PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedewald WT, Levy RI and Fredrickson DS:
Estimation of the concentration of low density lipoprotein
cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem. 18:499–502. 1972.PubMed/NCBI
|
|
31
|
International Diabetes Federation:
Recommended protocol for screening, management and follow up of
women with GDMImplementation Protocol Guidelines for Healthcare
Professionals. International Diabetes Federation; Brussels:
2015
|
|
32
|
Zhu WW, Fan L, Yang HX, Kong LY, Su SP,
Wang ZL, Hu YL, Zhang MH, Sun LZ, Mi Y, et al: Fasting plasma
glucose at 24–28 weeks to screen for gestational diabetes mellitus:
New environment from China. Diabetes Care. 36:2038–2040. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lindsay KL, Brennan L, Kennelly MA, Curran
S, Coffey M, Smith TP, Foley ME, Hatunic M and McAuliffe FM:
Maternal metabolic response to dietary treatment for
impairedglucose tolerance and gestational diabetes mellitus. Ir J
Med Sci. 2018.Doi: 10.1007/s11845-018-1744-y. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smith GN, Pudwell J, Walker M and Wen SW:
Risk estimation of metabolic syndrome at one and three years after
a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can.
34:836–841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Teodoro JS, Gomes AP, Varela AT, Duarte
FV, Rolo AP and Palmeira CM: Uncovering the beginning of diabetes:
The cellular redox status and oxidative stress as starting players
in hyperglycemic damage. Mol Cell Biochem. 376:103–110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Warrington JP, Gceorge EM, Palei AC,
Spradley FT and Granger JP: Recent advances in the understanding if
the pathophysiology of preeclampsia. Hypertension. 62:666–673.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Coustan DR: Diagnosis of gestational
diabetes. Scan J Clin Lab Invest Suppl. 244:27–33. 2014. View Article : Google Scholar
|
|
38
|
Popova P, Tkachuk A, Dronova A, Gerasimov
A, Kravchuk E, Bolshakova M, Rozdtestvenskaya O, Demidova K,
Nikolaeva A and Grineva E: Fasting glycemia at the first prenatal
visit and pregnancy outcomes in Russian women. Minerva Endocrinol.
41:477–485. 2016.PubMed/NCBI
|
|
39
|
Barrett HL, Nitert Dekker M, Mclntyre HD
and Callaway LK: Normalizing metabolism in diabetic pregnancy: Is
it time to target lipids? Diabetes Care. 37:1484–1493. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kingwell BA and Chapman MJ: Future of
high-density lipoprotein infusion therapies: Potential for clinical
management of vascular disease. Circulation. 128:1112–1121. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song GJ, Kim SM, Park KH, Kim J, Choi I
and Cho KH: SR-BI mediates high density lipoprotein (HDL)-induced
anti-inflammatory effect in macrophages. Biochem Biophys Res
Commun. 457:112–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Demirci O, Tuğrul AS, Dolgun N, Sözen H
and Eren S: Serum lipids level assessed in early pregnancy and risk
of pre-eclampsia. J Obstet Gynaecol Res. 37:1427–1432. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Matsumoto S, Gotoh N, Hishinuma S, Abe Y,
Shimizu Y, Katano Y and Ishihata A: The role of
hypertriglyceridemia in the development of atherosclerosis and
endothelial dysfunction. Nutrients. 6:1236–1250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Flood-Nichols SK, Stallings JD, Gotkin JL,
Tinnemore D, Napolitano PG and Ippolito DL: Elevated ratio of
maternal plasma ApoCIII to ApoCII in preeclampsia. Reprod Sci.
18:493–502. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Punthumapol C and Kittichotpanich B:
Comparative study of serum lipid concentrations in preeclampsia and
normal pregnancy. J Med Assoc Thai. 91:957–961. 2008.PubMed/NCBI
|
|
46
|
Kabiru W and Raynor B: Obstetric outcomes
associated with increase in BMI category during pregnancy. Am J
Obstet Gynecol. 191:928–932. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gallos I, Sivakumar K, Kilby M,
Coomarasamy A, Thangaratinam S and Vatish M: Pre-eclampsia is
associated with, and preceded by, hypertriglyceridaemia: A
meta-analysis. BJOG. 20:1321–1332. 2013. View Article : Google Scholar
|
|
48
|
Barrdel E, Larousserie F, Charlot-Rabiega
P, Coulomb-L'Herminé A and Devergne O: Human CD4+ CD25+ FoxP3+
regulatory T cells do not constitutively express IL-35. J Immunol.
181:6898–6905. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rasanen J, Girsen A, Lu X, Lapidus JA,
Standley M, Reddy A, Dasari S, Thomas A, Jacob T, Pouta A, et al:
Comprehensive maternal serum proteomic profiles of preclinical and
clinical preeclampsia. J Proteome Res. 9:4274–4281. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ozkan ZS, Simsek M, Ilhan F, Deveci D,
Godekmerdan A and Sapmaz E: Plasma IL-17, IL-35, Interferon-γ,
Socs3 and TGF-β levels in pregnant women with preeclampsia, and
their relation with severity of disease. J Matern Fetal Neonatal
Med. 27:1513–1517. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kassan M, Wecker A, Kadowitz P, Trebak M
and Matrogui K: CD4+CD25+FoxP3 regulatory T cells and vascular
dysfunction in hypertension. J Hypertens. 31:1939–1943. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sasaki S, Darmochwal-Kolarz D, Suzuki D,
Sakai M, Ito M, Shima T, Shiozaki A, Rolinski J and Saito S:
Proportion of peripheral blood and decidual CD4(+) CD25(bright)
regulatory T cells in pre-eclampsia. Clin Exp Immunol. 149:139–145.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Darmochwal-Kolarz D, Kludka-Sternik M,
Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B and
Oleszczuk J: The predominance of Th17 lymphocytes and decreased
number and function of Treg cells in preeclampsia. J Reprod
Immunol. 93:75–81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cao W, Xu W, Chen T, Wang X, Wang X, Qiu
J, Chen N and Mao Y:
CD4+CD25+FoxP3+ regulatory T cells
and cytokines interact with estradiol in case missed abortion. Exp
Ther Med. 7:417–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Glebezdina NS, Olina AA, Nekrasova IV and
Kuklina EM: Role of endogenous melatonin in the regulation of
Th17/Treg balance during pregnancy. Bull Exp Biol Med. 164:462–465.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Figueiredo AS and Schummacher A: The T
helper type 17/regulatory T cells paradigm in pregnancy.
Immunology. 148:13–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Onuegbu AJ, Olisekodiaka JM, Udo JU,
Umeononihu O, Amah UK, Okwara JE and Atuegbu C: Evaluation of
high-sensitivity C-reactive protwin and serum lipid profile in
southeastern nigerlan women with pre-ealampsia. Med Princ Pract.
24:276–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Khan NA: Role of T-cells in diabetic
pregnancy and macrosomia. Indian J Biochem Biophys. 44:344–349.
2007.PubMed/NCBI
|
|
59
|
Di Mario U, Dotta F, Gargiulo P,
Sutherland J, Andreani D, Guy K, Pachi A and Fallucca F: Immunology
in diabetes pregnancy: Activated Tcells in diabetic mother and
neonates. Diabetologia. 30:66–71. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lima VJ, Andrade CR, Ruschi GE and Sass N:
Serum lipid levels in pregnancies complicated by preeclampsia. Sao
Paulo Med J. 129:73–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
